Clinical Trial

Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to compare the efficacy of the 3-month formulation and 1-month formulation of triptorelin and to assess the short-term effects of the 3-month formulation of triptorelin on glucose and lipid metabolism, body composition, and bone density in Chinese ICPP patients.
Trial Details
NCT Number NCT06487143
Lead Sponsor Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions Central Precocious Puberty
Enrollment 134 participants
Start Date 2024-07-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-05